204 related articles for article (PubMed ID: 36051090)
1. Atypical Forms of Pyoderma Gangrenosum in Inflammatory Bowel Disease: Report of Four Cases and Literature Review.
Martinelli VF; Martinelli Barbosa P; Dantas de Oliveira LS; de Melo LALV; Casa Nova JM; de Brito CAA
Int Med Case Rep J; 2022; 15():449-456. PubMed ID: 36051090
[TBL] [Abstract][Full Text] [Related]
2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous onset of ulcerative colitis and disseminated pyoderma gangrenosum.
Neesse A; Michl P; Kunsch S; Ellenrieder V; Gress TM; Steinkamp M
Case Rep Gastroenterol; 2007 Oct; 1(1):110-5. PubMed ID: 21487555
[TBL] [Abstract][Full Text] [Related]
4. Long-term remission achieved in a rare case of pyoderma gangrenosum and ulcerative colitis with surgery and postoperative infliximab.
Xu X; Lv X; Huang Z; Han B; Huang Z; Li S; Fan J; Lv X
Rev Esp Enferm Dig; 2024 Jan; ():. PubMed ID: 38205697
[TBL] [Abstract][Full Text] [Related]
5. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
Kujundzić M
Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
[TBL] [Abstract][Full Text] [Related]
6. A case of pyoderma gangrenosum with ulcerative colitis treated with mesalazine.
Lee JI; Park HJ; Lee JY; Cho BK
Ann Dermatol; 2010 Nov; 22(4):422-5. PubMed ID: 21165212
[TBL] [Abstract][Full Text] [Related]
7. Development of pyoderma gangrenosum during therapy with infliximab.
Jaimes-López N; Molina V; Arroyave JE; Vasquez LA; Ruiz AC; Castaño R; Ruiz MH
J Dermatol Case Rep; 2009 Aug; 3(2):20-3. PubMed ID: 21886723
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease.
Argüelles-Arias F; Castro-Laria L; Lobatón T; Aguas-Peris M; Rojas-Feria M; Barreiro-de Acosta M; Soto-Escribano P; Calvo-Moya M; Ginard-Vicens D; Chaparro-Sánchez M; Hernández-Durán M; Castro-Senosiain B; Fernández-Villaverde A; García-Sánchez V; Domínguez-Muñoz E; Caunedo-Álvarez A; Herrerías-Gutiérrez JM
Dig Dis Sci; 2013 Oct; 58(10):2949-54. PubMed ID: 23828140
[TBL] [Abstract][Full Text] [Related]
9. Granulomatous pyoderma gangrenosum of the genitalia in the absence of Crohn's disease.
Kambil SM; Bhat RM; Dandekeri S
Indian J Sex Transm Dis AIDS; 2015; 36(1):67-9. PubMed ID: 26392658
[TBL] [Abstract][Full Text] [Related]
10. Pyoderma gangrenosum successfully treated with golimumab: Case report and review of the literature.
Diotallevi F; Campanati A; Radi G; Brisigotti V; Molinelli E; Brancorsini D; Offidani A
Dermatol Ther; 2019 Jul; 32(4):e12928. PubMed ID: 30980454
[TBL] [Abstract][Full Text] [Related]
11. Pustular pyoderma gangrenosum associated with ulcerative colitis in childhood. Report of two cases and review of the literature.
Barnes L; Lucky AW; Bucuvalas JC; Suchy FJ
J Am Acad Dermatol; 1986 Oct; 15(4 Pt 1):608-14. PubMed ID: 3771839
[TBL] [Abstract][Full Text] [Related]
12. Pyoderma gangrenosum in ulcerative colitis patient treated with vedolizumab: adsorptive granulocyte/monocyte apheresis as a new therapeutic option refractory cases - a case report and literature review.
Mastronardi M; Cavalcanti E; Labarile N; Armentano R; Gabriele F; Curlo M
Ther Adv Chronic Dis; 2023; 14():20406223231194190. PubMed ID: 37928629
[TBL] [Abstract][Full Text] [Related]
13. [Ulcerative colitis complicated by pyoderma gangrenosum and multiple aseptic abscesses].
Kita A; Hashimoto Y; Sato K; Itoi Y; Kasuga K; Tanaka H; Hosaka H; Kuribayashi S; Uraoka T
Nihon Shokakibyo Gakkai Zasshi; 2022; 119(11):1014-1021. PubMed ID: 36351620
[TBL] [Abstract][Full Text] [Related]
14. Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease.
Menachem Y; Gotsman I
Isr Med Assoc J; 2004 Feb; 6(2):88-90. PubMed ID: 14986464
[TBL] [Abstract][Full Text] [Related]
15. When Recurring Infections Mask an Atypical Presentation of Inflammatory Bowel Disease (IBD): A Re-Visitation and Literature Review.
Gildea DT; Davis W; Dapas N; Al Nakshabandi A; Krishnan L
Cureus; 2021 Dec; 13(12):e20215. PubMed ID: 35004035
[TBL] [Abstract][Full Text] [Related]
16. Disseminated refractory pyoderma gangraenosum during an ulcerative colitis flare. Treatment with infliximab.
Zampeli VA; Lippert U; Nikolakis G; Makrantonaki E; Tzellos TG; Krause U; Zouboulis CC
J Dermatol Case Rep; 2015 Sep; 9(3):62-6. PubMed ID: 26512301
[TBL] [Abstract][Full Text] [Related]
17. Management of Idiopathic Pyoderma Gangrenosum With Azathioprine As the Primary Adjunct in an Asian Man: A Case Report.
Nazir A; Zafar A
Cureus; 2022 May; 14(5):e25177. PubMed ID: 35746991
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory Cutaneous Lesions in Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab: An ECCO CONFER Multicentre Case Series.
Phillips FM; Verstockt B; Sebastian S; Ribaldone D; Vavricka S; Katsanos K; Slattery E; de Suray N; Flores C; Fries W; Vincenzi F; Capoferro E; Bachmann O; Kopylov U
J Crohns Colitis; 2020 Oct; 14(10):1488-1493. PubMed ID: 32318735
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Pyoderma Gangrenosum in Pediatric Inflammatory Bowel Disease.
Vaidy K; Winderman R; Rabinowitz SS; Schwarz SM
JPGN Rep; 2020 Nov; 1(2):e008. PubMed ID: 37206603
[TBL] [Abstract][Full Text] [Related]
20. Pyoderma gangrenosum in an ulcerative colitis patient during treatment with vedolizumab responded favorably to adsorptive granulocyte and monocyte apheresis.
Shibuya T; Haga K; Saeki M; Haraikawa M; Tsuchihashi H; Okahara K; Nomura O; Fukushima H; Murakami T; Ishikawa D; Ikeda S; Nagahara A
J Clin Apher; 2020 Sep; 35(5):488-492. PubMed ID: 32767842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
